Last reviewed · How we verify

NCT05318911

Antithrombotic Activities of a Novel Yogurt Drink

Completed NA Last updated 7 November 2022
What this trial tests

NA trial testing Novel yogurt drink in Cardiovascular Diseases in 20 participants. Completed in 30 September 2022.

Timeline
1 May 2022
Primary endpoint
30 September 2022
30 September 2022

Quick facts

Lead sponsorUniversity of Limerick
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposeprevention
Enrollment20
Start date1 May 2022
Primary completion30 September 2022
Estimated completion30 September 2022
Sites1 location across Ireland

Drugs / interventions tested

Conditions studied

Sponsor

University of Limerick

Who can join

Adults 18 to 60, any sex, with Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate antithrombotic activities of novel yoghurt drink in healthy adult volunteers

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

Other University of Limerick trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05318911.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing